These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27786)

  • 41. alpha 1-Adrenergic receptors of a smooth muscle cell line: guanine nucleotides do not regulate agonist affinities.
    Cornett LE; Ball DW; Norris JS
    J Recept Res; 1981-1982; 2(5-6):601-15. PubMed ID: 6130152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.
    Bylund DB
    J Pharmacol Exp Ther; 1981 Apr; 217(1):81-6. PubMed ID: 6110776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine.
    Greenberg DA; Snyder SH
    Life Sci; 1977 Mar; 20(6):927-31. PubMed ID: 191710
    [No Abstract]   [Full Text] [Related]  

  • 44. Dopamine binding to the alpha receptor in pregnant rabbit myometrium.
    Phillippe M; Barss V; Jackson KV; Valles L; Giannopoulos G
    Biochem Biophys Res Commun; 1987 Feb; 142(3):947-52. PubMed ID: 3030309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.
    Williams LT; Lefkowitz RJ
    Mol Pharmacol; 1977 Mar; 13(2):304-13. PubMed ID: 192992
    [No Abstract]   [Full Text] [Related]  

  • 46. alpha-Adrenergic receptors in human adipocyte membranes: direct determination by [3H]yohimbine binding.
    Tharp MD; Hoffman BB; Lefkowitz RJ
    J Clin Endocrinol Metab; 1981 Apr; 52(4):709-14. PubMed ID: 6110673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Displacement of alpha- and beta-radioligands by specific adrenergic agonists in rat pancreatic islets.
    Cherksey B; Mendelsohn S; Zadunaisky J; Altszuler N
    Pharmacology; 1983; 27(2):95-102. PubMed ID: 6310648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of trypsin on binding of [3H]epinephrine and [3H]-dihydroergocryptine to rat liver plasma membranes. Evidence for interconversion of binding sites.
    El-Refai MF; Exton JH
    J Biol Chem; 1980 Jun; 255(12):5853-8. PubMed ID: 6247349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
    Kawai Y; Powell A; Arinze IJ
    J Clin Endocrinol Metab; 1986 May; 62(5):827-32. PubMed ID: 3007555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization with [3H] dihydroergocryptine of the alpha-adrenergic receptor of the hepatic plasma membrane. Comparison with the beta-adrenergic receptor in normal and adrenalectomized rats.
    Guellaen G; Yates-Aggerbeck M; Vauquelin G; Strosberg D; Hanoune J
    J Biol Chem; 1978 Feb; 253(4):1114-20. PubMed ID: 203582
    [No Abstract]   [Full Text] [Related]  

  • 51. Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle.
    DeLean A; Lefkowitz RJ
    Nature; 1980 Jan; 283(5742):109-10. PubMed ID: 6243175
    [No Abstract]   [Full Text] [Related]  

  • 52. Demonstration of alpha-adrenoceptors in the rabbit bladder base and urethra with 3H-dihydroergocryptine ligand binding.
    Larsson B
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):188-94. PubMed ID: 6303047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
    Schmitz JM; Graham RM; Sagalowsky A; Pettinger WA
    J Pharmacol Exp Ther; 1981 Nov; 219(2):400-6. PubMed ID: 6270306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of antipsychotic drugs on dopamine-receptors on caudate calf].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):296-9, 317-8. PubMed ID: 1363315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do catecholestrogens interact with the in vitro binding of radioligands to catecholamine receptors?
    Hiemke C; Banger M; Ghraf R; Knuppen R
    J Steroid Biochem; 1983 Oct; 19(4):1469-74. PubMed ID: 6316030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 57. Two distinct alpha1-adrenergic receptor sites in rat liver: differential binding of (--)-[3H]dihydroergocryptine. Effects of guanine nucleotides and proteolysis; implications for a two-site model of alpha-receptor regulation.
    Geynet P; Ferry N; Borsodi A; Hanoune J
    Biochem Pharmacol; 1981 Jun; 30(12):1665-75. PubMed ID: 6268106
    [No Abstract]   [Full Text] [Related]  

  • 58. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective labeling of pre-synaptic receptors by 3H-dopamine, 3H-apomorphine and 3H-clonidine; labeling of post-synaptic sites by 3H-neuroleptics.
    Titeler M; Tedesco JL; Seeman P
    Life Sci; 1978 Aug; 23(6):587-91. PubMed ID: 29197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.